Bárcia R. N. et al (2015) “What makes umbilical cord tissue-derived mesenchymal stromal cells superior immunomodulators when compared to bone marrow-derived mesenchymal stromal cells?” Stem Cells International, Volume 2015, Article ID 583984 – doi: 10.1155/2015/583984.


Santos J. M. et al (2015) “Three-dimensional spheroid cell culture of umbilical cord tissue-derived mesenchymal stromal cells leads to enhanced paracrine induction of wound healing”. Stem Cell Research & Therapy 6:90 – doi: 10.1186/s13287-015-0082-5.


Martins J. P. et al (2014) “Towards an advanced therapy medicinal product based on mesenchymal stromal cells isolated from the umbilical cord tissue (UCX®): quality and safety data”. Stem Cell Research & Therapy 5:9 – doi:10.1186/scrt398.


Nascimento D. S. et al (2014) “Human umbilical cord tissue-derived MSCs (UCX®) attenuate remodeling following myocardial infarction by pro-angiogenic, anti-apoptotic and endogenous cell activation mechanisms”. Stem Cell Research & Therapy 5:5 – doi:10.1186/scrt394.


Gärtner A., et al. (2014) “Effects of umbilical cord tissue mesenchymal stem cells (UCX®) on rat sciatic nerve regeneration after neurotmesis injuries”. J. Stem Cells & Regenerative Medicine 23 Jan 2014; JSRM/Vol.10 No 1. JSRM Code: 010010300001EPA010214.


Santos J. M. et al. (2013) “The role of human umbilical cord tissue-derived mesenchymal stromal cells (UCX®) in the treatment of inflammatory arthritis”. J. Transl. Med. 11:18 – doi:10.1186/1479-5876-11-18.


Miranda J. P. et al. (2013) “The human umbilical cord tissue-derived MSC population UCX® promotes early motogenic effects on keratinocytes and fibroblasts and G-CSF-mediated mobilization of BM-MSCs: potential mechanisms for wound healing”. Cell Transplantation. doi: 10.3727/096368913X676231. [Epub ahead of print].